These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 21612828)

  • 1. Immune responses in piglets infected with highly pathogenic porcine reproductive and respiratory syndrome virus.
    Wang G; Song T; Yu Y; Liu Y; Shi W; Wang S; Rong F; Dong J; Liu H; Cai X; Zhou EM
    Vet Immunol Immunopathol; 2011 Aug; 142(3-4):170-8. PubMed ID: 21612828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune responses and protection by vaccine and various vaccine adjuvant candidates to virulent porcine reproductive and respiratory syndrome virus.
    Charerntantanakul W; Platt R; Johnson W; Roof M; Vaughn E; Roth JA
    Vet Immunol Immunopathol; 2006 Jan; 109(1-2):99-115. PubMed ID: 16165219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune responses of pigs inoculated with a recombinant fowlpox virus coexpressing GP5/GP3 of porcine reproductive and respiratory syndrome virus and swine IL-18.
    Shen G; Jin N; Ma M; Jin K; Zheng M; Zhuang T; Lu H; Zhu G; Jin H; Jin M; Huo X; Qin X; Yin R; Li C; Li H; Li Y; Han Z; Chen Y; Jin M
    Vaccine; 2007 May; 25(21):4193-202. PubMed ID: 17418456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive inductive effect of IL-2 on virus-specific cellular responses elicited by a PRRSV-ORF7 DNA vaccine in swine.
    Rompato G; Ling E; Chen Z; Van Kruiningen H; Garmendia AE
    Vet Immunol Immunopathol; 2006 Jan; 109(1-2):151-60. PubMed ID: 16162362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of a killed porcine reproductive and respiratory syndrome virus (PRRSV) vaccine treatment on virus shedding in previously PRRSV infected pigs.
    Nilubol D; Platt KB; Halbur PG; Torremorell M; Harris DL
    Vet Microbiol; 2004 Aug; 102(1-2):11-8. PubMed ID: 15288922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the host cell line on the vaccine efficacy of an attenuated porcine reproductive and respiratory syndrome virus.
    Calzada-Nova G; Husmann RJ; Schnitzlein WM; Zuckermann FA
    Vet Immunol Immunopathol; 2012 Jul; 148(1-2):116-25. PubMed ID: 22648044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An attenuated live vaccine based on highly pathogenic porcine reproductive and respiratory syndrome virus (HP-PRRSV) protects piglets against HP-PRRS.
    Tian ZJ; An TQ; Zhou YJ; Peng JM; Hu SP; Wei TC; Jiang YF; Xiao Y; Tong GZ
    Vet Microbiol; 2009 Jul; 138(1-2):34-40. PubMed ID: 19339125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: Clinical protection and cell-mediated immunity.
    Martelli P; Gozio S; Ferrari L; Rosina S; De Angelis E; Quintavalla C; Bottarelli E; Borghetti P
    Vaccine; 2009 Jun; 27(28):3788-99. PubMed ID: 19442420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the safety and efficacy of an attenuated live vaccine based on highly pathogenic porcine reproductive and respiratory syndrome virus.
    Yu X; Zhou Z; Cao Z; Wu J; Zhang Z; Xu B; Wang C; Hu D; Deng X; Han W; Gu X; Zhang S; Li X; Wang B; Zhai X; Tian K
    Clin Vaccine Immunol; 2015 May; 22(5):493-502. PubMed ID: 25739919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and protective efficacy of recombinant pseudorabies virus expressing the two major membrane-associated proteins of porcine reproductive and respiratory syndrome virus.
    Jiang Y; Fang L; Xiao S; Zhang H; Pan Y; Luo R; Li B; Chen H
    Vaccine; 2007 Jan; 25(3):547-60. PubMed ID: 16920232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine mRNA expression profiles in peripheral blood mononuclear cells from piglets experimentally co-infected with porcine reproductive and respiratory syndrome virus and porcine circovirus type 2.
    Shi KC; Guo X; Ge XN; Liu Q; Yang HC
    Vet Microbiol; 2010 Jan; 140(1-2):155-60. PubMed ID: 19854008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural infection with torque teno sus virus 1 (TTSuV1) suppresses the immune response to porcine reproductive and respiratory syndrome virus (PRRSV) vaccination.
    Zhang Z; Wang Y; Fan H; Lu C
    Arch Virol; 2012 May; 157(5):927-33. PubMed ID: 22327391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmid containing CpG oligodeoxynucleotides can augment the immune responses of pigs immunized with porcine reproductive and respiratory syndrome killed virus vaccine.
    Quan Z; Qin ZG; Zhen W; Feng XZ; Hong J; Fei ZH
    Vet Immunol Immunopathol; 2010 Aug; 136(3-4):257-64. PubMed ID: 20394988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HSP70 fused with GP3 and GP5 of porcine reproductive and respiratory syndrome virus enhanced the immune responses and protective efficacy against virulent PRRSV challenge in pigs.
    Li J; Jiang P; Li Y; Wang X; Cao J; Wang X; Zeshan B
    Vaccine; 2009 Feb; 27(6):825-32. PubMed ID: 19070639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical expression of IL-12, IL-10, IFN-α and IFN-γ in lymphoid organs of porcine reproductive and respiratory syndrome virus-infected pigs.
    Barranco I; Gómez-Laguna J; Rodríguez-Gómez IM; Quereda JJ; Salguero FJ; Pallarés FJ; Carrasco L
    Vet Immunol Immunopathol; 2012 Oct; 149(3-4):262-71. PubMed ID: 22889555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvants for porcine reproductive and respiratory syndrome virus vaccines.
    Charerntantanakul W
    Vet Immunol Immunopathol; 2009 May; 129(1-2):1-13. PubMed ID: 19157569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different European-type vaccines against porcine reproductive and respiratory syndrome virus have different immunological properties and confer different protection to pigs.
    Díaz I; Darwich L; Pappaterra G; Pujols J; Mateu E
    Virology; 2006 Aug; 351(2):249-59. PubMed ID: 16712895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD40 ligand expressed in adenovirus can improve the immunogenicity of the GP3 and GP5 of porcine reproductive and respiratory syndrome virus in swine.
    Cao J; Wang X; Du Y; Li Y; Wang X; Jiang P
    Vaccine; 2010 Nov; 28(47):7514-22. PubMed ID: 20851084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GM-CSF fused with GP3 and GP5 of porcine reproductive and respiratory syndrome virus increased the immune responses and protective efficacy against virulent PRRSV challenge.
    Wang X; Li J; Jiang P; Li Y; Zeshan B; Cao J; Wang X
    Virus Res; 2009 Jul; 143(1):24-32. PubMed ID: 19463718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in peripheral blood leukocyte subpopulations in piglets co-infected experimentally with porcine reproductive and respiratory syndrome virus and porcine circovirus type 2.
    Shi K; Li H; Guo X; Ge X; Jia H; Zheng S; Yang H
    Vet Microbiol; 2008 Jun; 129(3-4):367-77. PubMed ID: 18164875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.